"Key Players in Focus: Competitive Landscape of Cell Based Assay Market"

The Cell Based Assay Market was estimated at US$ 19.3 billion in 2021 and is expected to grow at a CAGR of 6.86% during 2022-2028 to reach US$ 31.78 billion in 2028.
North America led the Cell-Based Assay Market in 2021, driven by the introduction of new medications and technological advancements in end-use sectors, paving the way for promising market prospects. The market is poised for robust growth, propelled by innovative drug developments and technological breakthroughs.